When to start diabetes medication for a rare genetic condition

This study is looking at children and young people who have a rare form of diabetes caused by a genetic change in the KCNJ11 gene. These children can be treated with a medication called sulphonylurea instead of insulin injections. The researchers want to understand whether starting this medication early in life (before age 1) versus later (after age 1) helps protect brain development and learning abilities.

Children with this rare genetic diabetes often experience developmental delays, learning difficulties, epilepsy, and attention problems because the same genetic change affects the brain. Doctors know this medication works for the diabetes, but they don't yet know if starting it earlier in life might also help protect the brain and reduce these developmental challenges.